萊美藥業(300006.SZ)擬退出發起設立愛爾健康保險
格隆匯3月17日丨萊美藥業(300006.SZ)公佈,公司於2016年12月14日召開公司第三屆董事會第四十二次會議,審議通過了《關於參與發起設立健康保險公司的議案》。公司擬出資1.6億元與西藏愛爾醫療投資有限公司(現更名為愛爾醫療投資集團有限公司,“愛爾醫療”)、湖南電廣傳媒股份有限公司、永清環保股份有限公司、華測檢測認證集團股份有限公司和拓維信息系統股份有限公司參與設立愛爾健康保險股份有限公司(擬設)(“愛爾健康保險”)。截止目前,公司已出資320萬元用於愛爾健康保險籌建工作。
經公司與其他合作方友好協商共同簽署了《退出投資協議書的補充協議》,公司決定退出發起設立愛爾健康保險。根據補充協議約定補充協議簽署後公司將不再投資認購愛爾健康保險的股份,其他合作方不追究公司未依約投資認購等任何責任。根據協議約定愛爾醫療同意於補充協議簽署之日起15個工作日內退還公司前期已支付的籌建費320萬元。
截止目前,愛爾健康保險尚未正式進入設立階段,公司終止此次投資不會對公司整體業務發展和正常生產經營產生實質性的影響,不存在損害公司及全體股東利益的情形。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.